<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="expression-of-concern">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2025.8979</article-id>
<article-id pub-id-type="publisher-id">OR-54-5-08979</article-id>
<article-categories>
<subj-group>
<subject>Expression of Concern</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Expression of Concern] Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Tang</surname><given-names>Chunlan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Luo</surname><given-names>Hu</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Luo</surname><given-names>Dan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Heping</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Xiangdong</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>11</month><year>2025</year></pub-date>
<pub-date pub-type="epub"><day>26</day><month>08</month><year>2025</year></pub-date>
<volume>54</volume>
<issue>5</issue>
<elocation-id>146</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2025 Tang et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 39: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="object-of-concern" vol="39" page="611" id="RA1" xlink:href="10.3892/or.2017.6109" ext-link-type="doi">611&#x2013;618</related-article>, 2018; DOI: 10.3892/or.2017.6109</p>
<p>Following the publication of this paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that the immunohistochemical images shown in Figs. 1E and 5E appeared to show an overlapping section, even though Figs. 1 and 5 were intended to show the results of SHP2 and Ras expression experiments, respectively.</p>
<p>The authors were contacted by the Editorial Office to offer an explanation for this apparent anomaly in the presentation of the data in this paper; however, up to this time, no response from them has been forthcoming. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further.</p>
</body>
</article>
